Regeneron (Nasdaq: REGN) shares are dipping following negative commentary from Bloomberg Industries over it and Sanofi's (NYSE: SNY) colorectal cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE